HeartBeam, Inc (BEAT) Misses Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
HeartBeam Reports Third Quarter 2022 Financial Results
November 10, 2022 4:01 PM ESTÂ HeartBeam AIMI Platform Technology for use in Diagnosing Heart Attacks Submitted to FDA for Clearance
Company on Track for Initial FDA Submission of HeartBeam AIMIGo, the Telehealth Solution, in Q4 2022
AIMIGo Technology Receives Two Additional Patents
Company Plans to Broaden Product Portfolio Pipeline with Smartwatch Connectivity
Management to Host Webcast and Conference Call Today At 4:30 p.m. ET
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology... More
